PlainMeds provides educational information only. This is not medical advice. Always consult your doctor or pharmacist.

nirmatrelvir/ritonavir vs phenobarbital

Side-by-side comparison of nirmatrelvir/ritonavir and phenobarbital. Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.

major Known Drug Interaction

Anticonvulsants carbamazepine , phenobarbital, primidone, phenytoin ↓ nirmatrelvir/ritonavir Co-administration contraindicated due to potential loss of virologic response and possible resistance [see Contraindications (4) ] .

Recommendation: This combination is not recommended and should be avoided. Talk to your provider about using a different medication.

Drug Class
nirmatrelvir/ritonavir Antiviral (Protease Inhibitor Combination)
phenobarbital Anticonvulsant (Barbiturate)
Type
nirmatrelvir/ritonavir Prescription
phenobarbital Prescription
Summary
nirmatrelvir/ritonavir

Paxlovid is a medicine used to treat mild to moderate COVID-19 in adults. It helps prevent severe illness, hospitalization, or death in people at high risk.

phenobarbital

Phenobarbital is a medicine that can help control seizures and calm you down. It belongs to a class of drugs called barbiturates.

What It Treats
nirmatrelvir/ritonavir

Paxlovid treats mild to moderate COVID-19 in adults. You must be at high risk of your illness becoming severe. This includes needing to go to the hospital or possibly dying from COVID-19. Paxlovid is not for preventing COVID-19 before or after exposure.

phenobarbital

This medicine is used to treat generalized and partial seizures. Seizures are caused by unusual electrical activity in the brain. Phenobarbital helps to reduce this activity and prevent seizures.

How It Works
nirmatrelvir/ritonavir

Paxlovid contains two medicines, nirmatrelvir and ritonavir. Nirmatrelvir stops the virus from multiplying in your body. Ritonavir helps nirmatrelvir stay in your body longer so it can work better.

phenobarbital

Phenobarbital works by slowing down the activity of your brain and nervous system. It increases the effects of a natural chemical in the body called GABA. This helps to reduce seizures and promote relaxation.

Common Side Effects
nirmatrelvir/ritonavir
  • Change in taste
  • Diarrhea
phenobarbital
  • Drowsiness
  • Sedation
  • Lethargy
  • Vertigo
FAERS Reports
nirmatrelvir/ritonavir
  • COVID-19 22,774
  • COVID-19 coming back 20,089
  • Change in taste 7,316
  • Diarrhea 4,003
  • Feeling sick to your stomach 2,620
phenobarbital
  • Seizure 1,534
  • Medicine interacting with another medicine 635
  • Poisoning from different things 621
  • Prolonged seizure 482
  • Not responding to multiple medicines 442
Serious Warnings
nirmatrelvir/ritonavir

Paxlovid can interact with many other medicines, causing serious or life-threatening problems. Before taking Paxlovid, tell your doctor about all the medicines you take. Your doctor may need to adjust the dose of your other medicines or monitor you more closely.

phenobarbital

You should not take this medicine if you are allergic to barbiturates. Also, do not take it if you have a history of porphyria, severe liver problems, or breathing problems.

Pregnancy
nirmatrelvir/ritonavir

There is not enough information about nirmatrelvir's safety during pregnancy. Studies on ritonavir in pregnant women have not shown an increased risk of birth defects. Talk to your doctor about the risks and benefits of taking Paxlovid if you are pregnant or breastfeeding.

phenobarbital

Tell your doctor if you are pregnant or plan to become pregnant. Phenobarbital can harm an unborn baby. Talk to your doctor about the risks and benefits of taking this medicine while breastfeeding.

Also Compare, Nearby Drugs

Compare phenobarbital with

How to Read This nirmatrelvir/ritonavir vs phenobarbital Comparison

nirmatrelvir/ritonavir is classified in the Antiviral (Protease Inhibitor Combination) drug class, while phenobarbital sits within the Anticonvulsant (Barbiturate) class. Drugs from different classes work through distinct mechanisms, so a head-to-head comparison illustrates trade-offs rather than equivalence. Both drugs are prescription-only, so a licensed provider must authorize use.

Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, nirmatrelvir/ritonavir has 56,802 submissions while phenobarbital has 3,714. Those figures reflect cumulative reporting volume, not per-patient risk, so older, widely dispensed drugs typically look worse on count alone. These two drugs have a known major interaction flagged in FDA labeling, attributed to phenobarbital speeds up how fast your body breaks down the antiviral, which lowers the amount of medicine in your blood. this can stop the treatment from working and might lead to drug resistance.. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.

A table cannot substitute for clinical judgment. Effectiveness, tolerability, drug-drug interactions with your other medications, kidney and liver function, pregnancy status, insurance formulary, and price all feed into a decision that only a licensed prescriber can make responsibly. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This page is for educational purposes only, is not medical advice, and should not be used to self-switch between nirmatrelvir/ritonavir and phenobarbital - always consult your physician or pharmacist first.

Important: This comparison is for informational purposes only. Drug effects vary between individuals. Always consult your doctor or pharmacist for personalized medical advice.